Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Sarcoma 1NET 1Gastrointestinal 1Endocrine 1CNS 1

Conditions

Ovarian Neoplasms 370Endometrial Neoplasms 213Uterine Cervical Neoplasms 194Breast Neoplasms 111Fallopian Tube Neoplasms 100Colorectal Neoplasms 85Carcinoma, Non-Small-Cell Lung 76Neoplasms 66Pancreatic Neoplasms 61Stomach Neoplasms 55Prostatic Neoplasms 52Neoplasm Metastasis 52Lung Neoplasms 47Melanoma 44Carcinoma, Ovarian Epithelial 43Triple Negative Breast Neoplasms 39Squamous Cell Carcinoma of Head and Neck 36Esophageal Neoplasms 35Carcinoma, Renal Cell 35Colonic Neoplasms 31Urinary Bladder Neoplasms 30Head and Neck Neoplasms 30Peritoneal Neoplasms 29Uterine Neoplasms 28Carcinoma, Hepatocellular 27Vulvar Neoplasms 26Carcinoma, Transitional Cell 25Small Cell Lung Carcinoma 23Sarcoma 20Rectal Neoplasms 19

Interventions

liposomal doxorubicin 1dostarlimab 1Paclitaxel 1Nivolumab 1Ipilimumab 1Gemcitabine 1Doxorubicin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Adenocarcinoma, Clear Cell × Gynecologic × 90 days × Clear all
NCT06023862 2026-05-06

DOVE

Yonsei University

Phase 2 Recruiting
198 enrolled
Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Adenocarcinoma, Clear Cell

NCT03355976 2026-04-02

BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas

Brown University

Phase 2 Active not recruiting
46 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence, Adenocarcinoma, Clear Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡